Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Auto Inflammatory Diseases”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Not applicableStudy completedNCT00357071
What this trial is testing

Immune Responses to Antigens in Non-infectious Eye Inflammatory Diseases

Who this might be right for
Eye Diseases
National Eye Institute (NEI) 219
Not applicableStudy completedNCT02280902
What this trial is testing

Incidence and Risk Factors for Infections in Patient Treated With Corticosteroids, Immunosuppressive Drugs or Biotherapy for Immunologic and Inflammatory Diseases

Who this might be right for
Immunologic and Inflammatory Diseases
University Hospital, Bordeaux 72
Testing effectiveness (Phase 2)Ended earlyNCT01009281
What this trial is testing

An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's DiseaseInflammatory Bowel Disease
Novartis Pharmaceuticals 7
Large-scale testing (Phase 3)Study completedNCT02396212
What this trial is testing

Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals 19
Testing effectiveness (Phase 2)Study completedNCT01988506
What this trial is testing

Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisSystemic Lupus Erythematosus+11 more
Assistance Publique - Hôpitaux de Paris 81
Not applicableLooking for participantsNCT06435468
What this trial is testing

Biocollection of Rare Pediatric-onset of Autoimmune and Autoinflammatory Diseases

Who this might be right for
Systemic LupusAutoimmune DiseasesAutoinflammatory Disease+1 more
Hospices Civils de Lyon 400
Not applicableUnknownNCT01642706
What this trial is testing

Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments

Who this might be right for
Rheumatoid ArthritisOsteoarthritisSystemic Lupus Erythematosus+6 more
University Hospital, Montpellier 240
Early research (Phase 1)Study completedNCT01944228
What this trial is testing

Effects of Transvenous Vagus Nerve Stimulation on Immune Response: a Pilot Study

Who this might be right for
Inflammation
Medtronic Cardiac Rhythm and Heart Failure 22
Not applicableLooking for participantsNCT05383339
What this trial is testing

Biomarkers in Autoimmune Diseases, Vasculitis and Auto Inflammatory Diseases

Who this might be right for
Autoimmune DiseasesVasculitisAutoinflammatory Disease
Assistance Publique - Hôpitaux de Paris 2,250
Not applicableEnded earlyNCT04510467
What this trial is testing

Mental Health Consequences of COVID19 Infection in the French RMD Cohort

Who this might be right for
Covid19Systemic Autoimmune DiseaseInflammatory Rheumatism+1 more
University Hospital, Lille 296
Not applicableLooking for participantsNCT07718555
What this trial is testing

Host-microbiota Interactions in Auto-inflammatory Diseases

Who this might be right for
Autoinflammatory Diseases
Assistance Publique - Hôpitaux de Paris 300
Large-scale testing (Phase 3)Study completedNCT00632866
What this trial is testing

Hydroxychloroquine Versus Placebo in Primary Sjögren's Syndrome

Who this might be right for
Primary Sjögren's Syndrome
Assistance Publique - Hôpitaux de Paris 120
Testing effectiveness (Phase 2)UnknownNCT02000362
What this trial is testing

Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD)

Who this might be right for
Crohn's Disease
Kang Stem Biotech Co., Ltd. 24
Not applicableStudy completedNCT00769236
What this trial is testing

Evaluation of Intestinal Secretion of Antibodies and Auto-antibodies Associated With Crohn's Disease

Who this might be right for
Crohn's Disease
Assistance Publique Hopitaux De Marseille 160
Post-approval studies (Phase 4)Study completedNCT02232061
What this trial is testing

Long-term, Open-label, Multicenter Study Assessing Long-term Cardiovascular Risks

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 6
Testing effectiveness (Phase 2)Ended earlyNCT00069329
What this trial is testing

Anakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory Disease

Who this might be right for
Nervous System MalformationsArthropathy, NeurogenicUrticaria+1 more
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 43
Not applicableStudy completedNCT03569644
What this trial is testing

Quality of Life in Patients With Auto-inflammatory Diseases

Who this might be right for
Hereditary Autoinflammatory Diseases
Assistance Publique - Hôpitaux de Paris 39
Not applicableStudy completedNCT05961267
What this trial is testing

Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism

Who this might be right for
Arthritis, RheumatoidSpondylitis, AnkylosingLupus Erythematosus, Systemic+3 more
University Hospital, Bordeaux 318
Not applicableLooking for participantsNCT06387654
What this trial is testing

Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases

Who this might be right for
Autoimmune Bullous DermatosisDysimmune Dermatological DiseasesAuto-inflammatory Dermatological Diseases+1 more
University Hospital, Toulouse 800
Testing effectiveness (Phase 2)Study completedNCT00879658
What this trial is testing

Safety, Tolerability, Efficacy and Optimal Dose Finding Study of BAF312 in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Novartis Pharmaceuticals 297
Next Page